Lucia Sobrin – författare
Visar alla böcker från författaren . Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Häftad, Engelska, 2010
559 kr
Skickas inom 10-15 vardagar
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.);There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.
E-bok
PDF, Engelska, 2010732 kr
Läs direkt efter köp
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.);There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan''s Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.
- Nyhet
Häftad, Engelska, 2026
2 364 kr
Skickas inom 5-8 vardagar
BCSC Section 12, Retina and Vitreous, of the Academy's Basic and Clinical Science Course™ (BCSC®) provides essential, relevant guidance on diagnosing and managing vitreoretinal disease. Designed for ophthalmology residents, fellows, and practicing ophthalmologists, this comprehensive resource supports both exam preparation and real-world decision-making.Notable Revisions to BCSC Section 12 include: Expanded updates of age-related macular degeneration (AMD), including newly approved therapies such as intravitreal complement inhibitor medications (sample)Reorganized chapters on retinal diseases, Chapters 12 to 13, for improved clarity and continuityUpdates guidance on Chloroquine Toxicity based on the Academy’s 2026 Clinical Statement 15 new surgical and diagnostic videos have been added, including: subretinal gene therapy delivery (sample) and variations of secondary intraocular placementTwo new case studies (sample) designed to strengthen clinical decision-making in common retinal disease scenariosInside This Section: Retinal anatomy and pathophysiologyPosterior segment diseases, including retinal vascular disorders and detachmentsVitreous conditions and their managementOcular trauma affecting the retina and vitreousEmerging therapies, including gene therapy and evolving treatment approachesHundreds of clinical images, diagrams, and illustrations38 videos demonstrating key diagnostic and surgical techniques 10 interactive activities to reinforce understandingWho This Book Is For:Ophthalmology residents building their retina knowledge and preparing for examsRetina fellows seeking a structured retina referencePracticing ophthalmologists refreshing or expanding their retina knowledgeWhy Use BCSC Section 12:Developed by the American Academy of OphthalmologyComprehensive yet organized for efficient studyTrusted by ophthalmologists worldwideUsed as a core resource in ophthalmology training programs worldwideAbout the BCSC:The Basic and Clinical Science Course™ (BCSC®) is ophthalmology’s definitive clinical resource, used by residents and practicing ophthalmologists worldwide to support high-quality patient care.